There are 2789 resources available
1815P - Prognostic value of conventional type 1 dendritic cells in breast cancer patients
Presenter: Elisa Gobbini
Session: ePoster Display
1816P - CHEK2 gene somatic loss in breast tumors from carriers of germline CHEK2 mutations
Presenter: Aglaya Iyevleva
Session: ePoster Display
1817P - In silico identification of a BRCA1/miR-29/DNMT3A-3B axes involved in estrogen receptor expression of BRCA1-associated breast cancers
Presenter: Manuela Santarosa
Session: ePoster Display
1818P - Body mass index (BMI) is not a cancer risk factor for BRCA1/2 carriers: A systematic review and meta-analysis of case-control studies
Presenter: Valerio Gristina
Session: ePoster Display
1819P - Markers of breast cancer molecular types in metastasis-associated CTC subsets
Presenter: Olga Savelieva
Session: ePoster Display
1647TiP - Antiandrogen therapy and TMPRSS2 status: How prostate cancer patients are protected from COVID-19 pandemic
Presenter: Melanie Claps
Session: ePoster Display
1648P - Phased avelumab combined with chemotherapy as first-line treatment in extensive stage small cell lung cancer (PAVE): A phase II Hellenic Cooperative Oncology Group study
Presenter: Helena Linardou
Session: ePoster Display
1650P - Adoption and early clinical outcomes of atezolizumab (atezo) + carboplatin and etoposide (CE) in patients with extensive-stage small cell lung cancer (ES-SCLC) in the real-world (RW) setting
Presenter: David Chun Cheong Tsui
Session: ePoster Display
1651P - Phase I study of ramucirumab in combination with irinotecan plus cisplatin in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)
Presenter: Toshiaki Takahashi
Session: ePoster Display